ELAN vs INCY · rev $2.74B vs P/E 14, rev $5.14B
Elanco Animal Health (ELAN) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
ELAN currently screens at market cap $11.80B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the ELAN and INCY stock pages for the full models.
Not investment advice.